CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Dr. James Weber, M.D., Announces Planned Transition from CEO of The Specialty Alliance

Neutral
AI Analysis

Summary

Dr. James Weber, M.D., announces planned retirement from CEO role at The Specialty Alliance after 40 years of service and will transition to a strategic advisory position.

Importance:2/10
Sentiment:
0.00
management changeCEO transitionretirement

Read the original article

Published by PR Newswire Pharma on September 24, 2026 2:00 PM

Read Original